Home › results
 

Keywords :   


Tag: results

Results of Phase 2 Study of Mercks Investigational Beta-Lactamase Inhibitor Relebactam in Combination with Imipenem/Cilastatin Presented at ASM Microbe

2016-06-20 18:30:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. Pivotal Phase 3 Studies Ongoing in Treatment of Serious Bacterial Infections KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that a Phase 2 study of relebactam, the companys investigational beta-lactamase inhibitor, in combination with imipenem/cilastatin (an approved carbapenem antibiotic), in patients with complicated urinary tract infections, met its primary endpoint. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558orRobert Consalvo, (908) 295-0928orInvestor:Teri Loxam, (908) 740-1986orAmy Klug, (908) 740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: results study presented combination

 

Lead Test Results

2016-06-18 00:30:34| PortlandOnline

17 June 2016 application/vnd.openxmlformats-officedocument.spreadsheetml.sheet, 74kbCategory: Test Results

Tags: results test lead test results

 
 

May 2016 Primary Election - Official Results

2016-06-14 22:12:24| PortlandOnline

Tags: results primary official election

 

05.23.12 -- Multipoint Monitoring System Produces Results At Ammonia Plant

2016-06-13 17:04:31| chemicalonline Home Page

05/23/12Chemical Online Newsletter

Tags: results system plant monitoring

 

Alzeca Biosciences' ADx Imaging Technology Shows Positive Results In Early Detection Of Alzheimer's

2016-06-13 07:00:28| pollutiononline Home Page

Alzeca Biosciences announced successful preliminary preclinical results for ADx, its innovative, proprietary diagnostic imaging technology, designed to enable diagnosis of Alzheimer’s disease a decade or more before the onset of symptoms of cognitive decline

Tags: results technology shows early

 

Sites : [315] [316] [317] [318] [319] [320] [321] [322] [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] next »